NEW YORK--(BUSINESS WIRE)-- The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Wednesday, September 22. The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 2,000 people are expected to attend. Presenting companies include:
Actelion | DENTSPLY International | PerkinElmer, Inc. | ||
Agilent Technologies, Inc. | DiaSorin | QIAGEN N.V. | ||
Alere Inc. | Dr. Reddy's Laboratories | Regeneron Pharmaceuticals, Inc. | ||
Alexion Pharmaceuticals, Inc | F. Hoffmann-La Roche Ltd. | ResMed | ||
Allergan, Inc. | Genoptix, Inc. | Shanghai Fosun Pharma Group | ||
Amgen Inc. | Genzyme Corporation | Sigma-Aldrich Corporation | ||
Baxter | Gilead Sciences, Inc. | Sino Biopharmaceutical Ltd. | ||
Bayer AG | H. Lundbeck A/S | Sirona Dental Systems, Inc. | ||
Biogen Idec | Henry Schein, Inc. | Smith & Nephew | ||
BioMarin Pharmaceutical Inc. | Human Genome Sciences, Inc. | STERIS Corporation | ||
BioMed Realty Trust, Inc. | Illumina, Inc. | Teva Pharmaceutical Industries Ltd. | ||
BioMerieux SA | Life Technologies | Thermo Fisher Scientific | ||
Bristol-Myers Squibb Company | Medtronic Inc. | Thoratec Corporation | ||
Celera Corporation | Merck & Co., Inc. | United Therapeutics Corporation | ||
Celgene Corporation | Merck KGaA | Vertex Pharmaceuticals | ||
Cephalon, Inc. | Meridian Bioscience, Inc. | Warner Chilcott | ||
Cepheid | Mettler-Toledo International, Inc. | Waters Corporation | ||
Charles River Laboratories | Myriad Genetics, Inc. | West Pharmaceutical Services, Inc. | ||
China Shineway Pharmaceutical | Novo Nordisk Inc. | |||
Crucell | Novozymes A/S | |||
Danaher Corporation | Pall Corporation | |||
*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences. |
||||
Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.
UBS draws on its 150-year heritage to serve private, institutional and corporate clients worldwide, as well as retail clients in Switzerland. We combine our wealth management, investment banking and asset management businesses with our Swiss operations to deliver superior financial solutions and manage CHF 2.2 trillion in invested assets.
UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 37% of its employees working in the Americas, 37% in Switzerland, 16% in the rest of Europe and 10% in Asia Pacific. UBS employs about 64,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).
CONTACT:
UBS
Kelly Smith, 212-882-5699
www.ubs.com
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Professional Services Banking Finance Research Science
MEDIA:
Logo |